NANOTOX 2014, 7th International Nanotoxicology Congress
NANOTOX 2014,第七届国际纳米毒理学大会
基本信息
- 批准号:8718354
- 负责人:
- 金额:$ 0.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-17 至 2015-04-16
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAreaBiologicalBiologyCell physiologyCellsCharacteristicsChemicalsChemistryCommunitiesComputer SimulationCongressesCosmeticsDataDimensionsDisciplineDoseDrug KineticsEcosystemEngineeringEnvironmentEnvironmental HealthEventExposure toFosteringGoalsGray unit of radiation doseGrowthHealthHumanImmune responseIndustryInternationalKnowledgeLaboratoriesLifeManufacturer NameMeleagris gallopavoMethodologyMethodsModelingMolecularMolecular MachinesMolecular Mechanisms of ActionNanotechnologyOccupationalPaperParticipantProductionPubMedPublic HealthPublicationsPublishingRegulationResearchResearch PersonnelRiskRisk AssessmentSafetyScientistSemiconductorsSeriesSocietiesSurfaceSystems BiologyTechnologyTissuesToxic effectToxicologyWorkbasedesignexperienceinnovationlecturesmanmeetingsnanonanomaterialsnanomedicinenanoparticlenanotoxicologyprogramspublic health relevanceresponsescientific organizationsymposium
项目摘要
DESCRIPTION (provided by applicant):
Recent advances in nanotechnology have revolutionized all aspects of life, from engineering, semiconductors, building materials to cosmetics and nanomedicine. The unique physico-chemical characteristics combined with the vast surface area make the biological effects of nano-materials and their interactions with cells, tissues and biofluids largely unpredictable. The increasing use of engineered nanomaterials raises concerns about inadvertent exposure to these materials and the potential for adverse effects on human health and the environment. As a result of this, a new and explosively developing field of toxicology - nanotoxicology - has emerged. Experimental work in the field of nanotoxicology is progressing at exponential rate. In spite of this, there is still a fundamental lack of data on the potential impacts of nanomaterials n human health, and the environment, including natural ecosystems. Filling this gap of knowledge will require an unprecedented degree of national and international coordination between scientific organizations, regulatory agencies, and stakeholders. The proposed International Conference Nanotoxicology-2014 is an important step in this direction. The International Conference Nanotoxicology-2014 - to be held in Antalya, Turkey from April 23 through 26, 2014 - will bring together current research leaders in the field of toxicology of nanomaterial's from material scientists, chemists and manufacturers to molecular toxicologists, risk assessment experts as well as clinicians and translational scientists involved in biomedical applications of nanoparticles. Since 2006, when the first International conference on nanotoxicology has been initiated and organized in the US (Miami), a series of bi-annual meetings was conducted in Zurich (2008), Edinburgh (2010), and Beijing (2012). These conferences represented the major scientific events in the field of Nano toxicology whereby most innovative and significant breakthrough results in the emerging discipline were strategically disseminated and made available for the research community of scientists, representatives of nanomaterial's manufacturing industries, public health officials and experts in risk assessment/regulatory issues. The primary goal of the conference is to create the opportunity for cross disciplinary discussions for investigators with different fields of expertise working together to understand the
chemistry, biology, molecular mechanisms of action and toxicity of nanomaterial's, hence to provide basis for risk assessments thus facilitating the design and production of nanomaterial's with minimized adverse effects on human health and the environment. The topics of the conference are focused on the latest most innovative areas of the exploding discipline of nanotoxicology: nanotoxicology and human toxicology, nano-environmental health and safety, eco-nanotoxicology, dose-response paradigm, molecular mechanisms of nontoxicity, immune responses to nanoparticles, nanomedicine, pharmacokinetics and particokinetics, nano-bio interface and nanobiomaterials, exposure scenarios and risk assessment of nanomaterials, systems biology approaches to nanosafety, In Silico modeling approaches including nano-QSARs, regulatory challenges of nanotechnology risks. A series of lectures on "Methods in nanosafety research" for young investigators will also be included in the program of the conference. Two special round-table discussions will be focused on the world-wide strategic research agenda in the field of nanosafety. Overall, the topics of the conference will address the major directions of research relevant to concerns associated with the environmental, occupational and biomedical exposures to nanomaterials. The conference will create opportunities for participants to present and share experiences, explore new directions and debate topics with experts from across the globe in the field of nanotoxicology.
描述(由申请人提供):
纳米技术的最新进展彻底改变了生活的各个方面,从工程、半导体、建筑材料到化妆品和纳米医学。独特的物理化学特性与巨大的表面积相结合,使得纳米材料的生物效应及其与细胞、组织和生物体液的相互作用在很大程度上难以预测。工程纳米材料的使用越来越多,引起了人们对无意接触这些材料以及可能对人类健康和环境产生不利影响的担忧。因此,出现了一个爆炸性发展的毒理学新领域——纳米毒理学。纳米毒理学领域的实验工作正在以指数速度进展。尽管如此,仍然根本缺乏关于纳米材料对人类健康和环境(包括自然生态系统)潜在影响的数据。填补这一知识空白需要科学组织、监管机构和利益相关者之间进行前所未有的国内和国际协调。拟议的 2014 年纳米毒理学国际会议是朝这个方向迈出的重要一步。 2014 年纳米毒理学国际会议将于 2014 年 4 月 23 日至 26 日在土耳其安塔利亚举行,届时纳米材料毒理学领域的当前研究领导者将齐聚一堂,从材料科学家、化学家和制造商到分子毒理学家、风险评估专家,以及参与纳米颗粒生物医学应用的临床医生和转化科学家。自2006年在美国(迈阿密)发起并组织第一届国际纳米毒理学会议以来,一系列每两年一次的会议分别在苏黎世(2008年)、爱丁堡(2010年)和北京(2012年)举行。这些会议代表了纳米毒理学领域的重大科学事件,战略性地传播了新兴学科中最具创新性和重大突破性的成果,并提供给科学家研究界、纳米材料制造行业代表、公共卫生官员和风险专家评估/监管问题。会议的主要目标是为不同专业领域的研究人员创造跨学科讨论的机会,共同了解
纳米材料的化学、生物学、作用分子机制和毒性,从而为风险评估提供基础,从而促进纳米材料的设计和生产,最大限度地减少对人类健康和环境的不利影响。会议主题集中在纳米毒理学爆炸性学科的最新最具创新性的领域:纳米毒理学和人类毒理学、纳米环境健康与安全、生态纳米毒理学、剂量反应范式、无毒分子机制、纳米粒子的免疫反应、纳米医学、药代动力学和粒子动力学、纳米生物界面和纳米生物材料、纳米材料的暴露场景和风险评估、纳米安全的系统生物学方法、计算机建模方法,包括纳米 QSAR,纳米技术风险的监管挑战。为青年研究者举办的“纳米安全研究方法”系列讲座也将列入会议议程。两次特别圆桌讨论将重点关注纳米安全领域的全球战略研究议程。总体而言,会议的主题将讨论与环境、职业和生物医学接触纳米材料相关的问题相关的主要研究方向。会议将为与会者提供展示和分享经验、探索新方向以及与来自全球纳米毒理学领域的专家辩论主题的机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Valerian E Kagan其他文献
Bioactive Oxylipins in Infants and Children With Congenital Heart Disease Undergoing Pediatric Cardiopulmonary Bypass
患有先天性心脏病并接受小儿心肺搭桥术的婴儿和儿童中的生物活性氧脂
- DOI:
10.1097/pcc.0000000000002036 - 发表时间:
2020-01-01 - 期刊:
- 影响因子:4.1
- 作者:
Nahmah Kim;Catherine Gretchen;Vladimir B. Ritov;P. Kochanek;G. Balasubramani;Elizabeth M. Kenny;Mahesh Sharma;M. Viegas;Clifton Callaway;Valerian E Kagan;H. Bayır - 通讯作者:
H. Bayır
Antioxidant paradoxes of phenolic compounds: peroxyl radical scavenger and lipid antioxidant, etoposide (VP-16), inhibits sarcoplasmic reticulum Ca(2+)-ATPase via thiol oxidation by its phenoxyl radical.
酚类化合物的抗氧化悖论:过氧自由基清除剂和脂质抗氧化剂依托泊苷 (VP-16),通过其苯氧基自由基的硫醇氧化来抑制肌浆网 Ca(2 )-ATP 酶。
- DOI:
- 发表时间:
1995 - 期刊:
- 影响因子:3.9
- 作者:
V. Ritov;Radoslav Goldman;D. Stoyanovsky;Elizabeth V. Menshikova;Valerian E Kagan - 通讯作者:
Valerian E Kagan
Role of coenzyme Q and superoxide in vitamin E cycling.
辅酶 Q 和超氧化物在维生素 E 循环中的作用。
- DOI:
10.1007/978-1-4899-1789-8_20 - 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
Valerian E Kagan;Y. Tyurina;Y. Tyurina;Eric Witt - 通讯作者:
Eric Witt
Binding of fatty acids facilitates oxidation of cysteine-34 and converts copper-albumin complexes from antioxidants to prooxidants.
脂肪酸的结合促进了半胱氨酸 34 的氧化,并将铜-白蛋白复合物从抗氧化剂转化为促氧化剂。
- DOI:
10.1016/s0003-9861(03)00091-2 - 发表时间:
2003-05-01 - 期刊:
- 影响因子:3.9
- 作者:
Y. Gryzunov;A. Arroyo;Jean;Qing Zhao;V. Tyurin;Carl A. Hubel;R. G;ley;ley;Yury A. Vladimirov;Robert N. Taylor;Valerian E Kagan - 通讯作者:
Valerian E Kagan
Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis
磷脂酰乙醇胺和磷脂酰丝氨酸的重新分布先于再灌注诱导的细胞凋亡
- DOI:
- 发表时间:
1997-09-14 - 期刊:
- 影响因子:0
- 作者:
N. Maulik;Valerian E Kagan;V. Tyurin;D. K. Das - 通讯作者:
D. K. Das
Valerian E Kagan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Valerian E Kagan', 18)}}的其他基金
Therapeutic targeting MDSC-mediated immune suppression in cancer
针对癌症中 MDSC 介导的免疫抑制的治疗
- 批准号:
10340589 - 财政年份:2021
- 资助金额:
$ 0.8万 - 项目类别:
Therapeutic targeting MDSC-mediated immune suppression in cancer
针对癌症中 MDSC 介导的免疫抑制的治疗
- 批准号:
10540357 - 财政年份:2021
- 资助金额:
$ 0.8万 - 项目类别:
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
蛋白氧化磷脂相互作用决定上皮细胞命运和哮喘控制
- 批准号:
10593942 - 财政年份:2020
- 资助金额:
$ 0.8万 - 项目类别:
Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators
促铁死亡脂氧合酶的选择性抑制剂 - 下一代放射减缓剂
- 批准号:
10176413 - 财政年份:2020
- 资助金额:
$ 0.8万 - 项目类别:
Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators
促铁死亡脂氧合酶的选择性抑制剂 - 下一代放射减缓剂
- 批准号:
10408142 - 财政年份:2020
- 资助金额:
$ 0.8万 - 项目类别:
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
蛋白氧化磷脂相互作用决定上皮细胞命运和哮喘控制
- 批准号:
10375454 - 财政年份:2020
- 资助金额:
$ 0.8万 - 项目类别:
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
蛋白氧化磷脂相互作用决定上皮细胞命运和哮喘控制
- 批准号:
10593942 - 财政年份:2020
- 资助金额:
$ 0.8万 - 项目类别:
The molecular basis of cardiolipin-protein interactions implicated in intrinsic apoptosis
心磷脂-蛋白质相互作用的分子基础涉及内在细胞凋亡
- 批准号:
9342976 - 财政年份:2016
- 资助金额:
$ 0.8万 - 项目类别:
Intra- and extra-cellular signaling by Cardiolipin in Lung injury
肺损伤中心磷脂的细胞内和细胞外信号传导
- 批准号:
8643330 - 财政年份:2014
- 资助金额:
$ 0.8万 - 项目类别:
Ferroptosis as a Death Mechanism in Lung Injury - Project 2
铁死亡作为肺损伤的死亡机制 - 项目 2
- 批准号:
10399560 - 财政年份:2014
- 资助金额:
$ 0.8万 - 项目类别:
相似国自然基金
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
D.formicigenerans菌通过调控FoxP3-Treg影响PD-1抑制剂所致免疫相关不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 0.8万 - 项目类别:
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
检查全球预算收入计划对接受化疗的癌症患者提供的护理成本和质量的影响
- 批准号:
10734831 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Constructing a large-scale biomedical knowledge graph using all PubMed abstracts and PMC full-text articles and its applications
利用所有PubMed摘要和PMC全文文章构建大规模生物医学知识图谱及其应用
- 批准号:
10648553 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Does prenatal immune challenge result in increased extra-axial CSF volume?
产前免疫挑战是否会导致轴外脑脊液体积增加?
- 批准号:
10647969 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Project 1: Greenspace to build resilience to climate change impacts on health: The good, the bad, and the future
项目 1:绿色空间,增强抵御气候变化对健康影响的能力:好的、坏的和未来
- 批准号:
10835396 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别: